FAQ: ACOG's Recommendations on Cannabis Use During Pregnancy and Breastfeeding
Summary
The American College of Obstetricians & Gynecologists (ACOG) has released new recommendations urging people to avoid marijuana during pregnancy and breastfeeding and calling for universal screening by healthcare providers. These guidelines aim to address potential risks and represent significant medical guidance that could impact both patient care and cannabis industry practices.
What are the main recommendations from ACOG regarding cannabis use?
ACOG recommends that people avoid marijuana during pregnancy and breastfeeding, and that doctors regularly ask patients about marijuana use throughout their pregnancy journey to better address possible risks.
Why is ACOG recommending against cannabis use during pregnancy and breastfeeding?
The recommendations are based on addressing possible risks associated with marijuana use during these critical periods, though the specific risks are not detailed in the content provided.
How should healthcare providers implement these recommendations?
Doctors should conduct universal screening by regularly asking patients about marijuana use throughout their pregnancy journey to identify and address potential concerns.
What role might cannabis companies play in response to these recommendations?
Medical marijuana companies like Cresco Labs Inc. could increase their consumer education programs to address these health concerns and promote responsible use.
When were these recommendations released?
The recommendations were released recently, as indicated by the September 2025 date reference in the CNN article link, though the exact publication date isn’t specified in the content.
Where can I find more detailed information about these recommendations?
More information can be found through the provided CNN article link at https://edition.cnn.com/2025/09/18/health/cannabis-pregnancy-acog-recommendation and the full article at CannabisNewsWire.
Who is affected by these new recommendations?
Expectant mothers, breastfeeding individuals, healthcare providers (particularly OB/GYNs), and cannabis companies are all affected by these guidelines.
What is CNW420 and how does it relate to this topic?
CNW420 is a daily cannabis industry news service that published this article, providing updates on regulatory developments and their impact on financial markets in the cannabis sector.
How can I stay updated on cannabis industry developments like this?
You can visit CannabisNewsWire.com daily or text CANNABIS to 888-902-4192 (U.S. mobile phones only) to receive SMS alerts for the latest cannabis industry news.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 218813